Frequently Asked Questions
The market is segmented based on Asia-Pacific Next Generation Sequencing (NGS) in Cancer Diagnostic Market, By Cancer Type (Lung, Breast, Colorectal, Prostrate, Stomach, Cervical, Leukemia, and Others), Product and Service (Kits, Software, and Services and Instruments), Technologies (Panels/Targeted Sequencing and Resequencing, Whole Exome Sequencing, Whole Genome Sequencing, RNA Sequencing, and Other Sequencing Technologies), Workflow (NGS Sequencing, NGS Data Analysis, and NGS Pre-Sequencing), Application (Screening, Companion Diagnostics, and Others), End User (Pathology Labs, Hospitals, Oncology Centers and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
.
The Asia Pacific Next Generation Sequencing Ngs In Cancer Diagnostic Market size was valued at USD 684.99 USD Million in 2022.
The Asia Pacific Next Generation Sequencing Ngs In Cancer Diagnostic Market is projected to grow at a CAGR of 15.6% during the forecast period of 2023 to 2030.
The market report covers data from the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
